Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34698568)

  • 1. Deep Learning for Prediction of N2 Metastasis and Survival for Clinical Stage I Non-Small Cell Lung Cancer.
    Zhong Y; She Y; Deng J; Chen S; Wang T; Yang M; Ma M; Song Y; Qi H; Wang Y; Shi J; Wu C; Xie D; Chen C;
    Radiology; 2022 Jan; 302(1):200-211. PubMed ID: 34698568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics for Survival Risk Stratification of Clinical and Pathologic Stage IA Pure-Solid Non-Small Cell Lung Cancer.
    Wang T; She Y; Yang Y; Liu X; Chen S; Zhong Y; Deng J; Zhao M; Sun X; Xie D; Chen C
    Radiology; 2022 Feb; 302(2):425-434. PubMed ID: 34726531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer.
    Song J; Wang L; Ng NN; Zhao M; Shi J; Wu N; Li W; Liu Z; Yeom KW; Tian J
    JAMA Netw Open; 2020 Dec; 3(12):e2030442. PubMed ID: 33331920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study.
    Hosny A; Parmar C; Coroller TP; Grossmann P; Zeleznik R; Kumar A; Bussink J; Gillies RJ; Mak RH; Aerts HJWL
    PLoS Med; 2018 Nov; 15(11):e1002711. PubMed ID: 30500819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
    Li B; Cui Y; Diehn M; Li R
    JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
    Huang Y; Liu Z; He L; Chen X; Pan D; Ma Z; Liang C; Tian J; Liang C
    Radiology; 2016 Dec; 281(3):947-957. PubMed ID: 27347764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Deep Learning Model for Non-Small Cell Lung Cancer Survival.
    She Y; Jin Z; Wu J; Deng J; Zhang L; Su H; Jiang G; Liu H; Xie D; Cao N; Ren Y; Chen C
    JAMA Netw Open; 2020 Jun; 3(6):e205842. PubMed ID: 32492161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET/CT based cross-modal deep learning signature to predict occult nodal metastasis in lung cancer.
    Zhong Y; Cai C; Chen T; Gui H; Deng J; Yang M; Yu B; Song Y; Wang T; Sun X; Shi J; Chen Y; Xie D; Chen C; She Y
    Nat Commun; 2023 Nov; 14(1):7513. PubMed ID: 37980411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel deep learning prognostic system improves survival predictions for stage III non-small cell lung cancer.
    Yang L; Fan X; Qin W; Xu Y; Zou B; Fan B; Wang S; Dong T; Wang L
    Cancer Med; 2022 Nov; 11(22):4246-4255. PubMed ID: 35491970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer.
    Zhang N; Liang R; Gensheimer MF; Guo M; Zhu H; Yu J; Diehn M; Loo BW; Li R; Wu J
    Theranostics; 2020; 10(25):11707-11718. PubMed ID: 33052242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative CT-based Deep Learning Model for Predicting Disease-Free Survival in Patients with Lung Adenocarcinomas.
    Kim H; Goo JM; Lee KH; Kim YT; Park CM
    Radiology; 2020 Jul; 296(1):216-224. PubMed ID: 32396042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer.
    Chen DT; Hsu YL; Fulp WJ; Coppola D; Haura EB; Yeatman TJ; Cress WD
    J Natl Cancer Inst; 2011 Dec; 103(24):1859-70. PubMed ID: 22157961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
    Mao Q; Xia W; Dong G; Chen S; Wang A; Jin G; Jiang F; Xu L
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1784-1792.e3. PubMed ID: 29554790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study.
    Jiang Y; Liang X; Han Z; Wang W; Xi S; Li T; Chen C; Yuan Q; Li N; Yu J; Xie Y; Xu Y; Zhou Z; Poultsides GA; Li G; Li R
    Lancet Digit Health; 2021 Jun; 3(6):e371-e382. PubMed ID: 34045003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patients.
    Boros A; Lacroix L; Lacas B; Adam J; Pignon JP; Caramella C; Planchard D; de Montpreville V; Deutsch E; Levy A; Besse B; Le Pechoux C
    Oncotarget; 2017 Apr; 8(15):25189-25199. PubMed ID: 28445990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly expressed mRNA signature for predicting survival in patients with stage I/II non-small-cell lung cancer after operation.
    Ma N; Si L; Yang M; Li M; He Z
    Sci Rep; 2021 Mar; 11(1):5855. PubMed ID: 33712694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non-Small-Cell Lung Cancer.
    Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
    Clin Lung Cancer; 2021 Mar; 22(2):120-126.e3. PubMed ID: 33485802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.